Old Web
English
Sign In
Acemap
>
authorDetail
>
Tim van de Venne
Tim van de Venne
University of Amsterdam
Metformin
Everolimus
Medicine
Oncology
Cancer
4
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase Ib study of everolimus combined with metformin for patients with advanced cancer
2018
Investigational New Drugs
Remco J. Molenaar
Tim van de Venne
Mariëtte J. Weterman
Ron A. A. Mathot
Heinz-Josef Klümpen
Dick J. Richel
Johanna W. Wilmink
Show All
Source
Cite
Save
Citations (12)
Survival analysis of a phase IB/II study of everolimus and metformin for patients with advanced cancer.
2017
Journal of Clinical Oncology
Remco J. Molenaar
Tim van de Venne
Mariëtte J. Weterman
Ron A. A. Mathot
Heinz-Josef Klümpen
D. J. Richel
Johanna W. Wilmink
Show All
Source
Cite
Save
Citations (0)
Phase I study of everolimus combined with metformin for patients with advanced cancer.
2016
Journal of Clinical Oncology
Remco J. Molenaar
Tim van de Venne
Mariëtte J. Weterman
Heinz-Josef Klümpen
Ron A. A. Mathot
Dirk Richel
Johanna W. Wilmink
Show All
Source
Cite
Save
Citations (0)
Phase I study of everolimus combined with metformin for patients with advanced cancer.
2016
Journal of Clinical Oncology
Remco J. Molenaar
Tim van de Venne
Mariëtte J. Weterman
Heinz-Josef Klümpen
Ron A. A. Mathot
D. J. Richel
Johanna W. Wilmink
Show All
Source
Cite
Save
Citations (0)
1